Stay Updated with the Latest Vanguard Equity Income Fund Admiral Shares VEIRX News in Real Time
Find VEIRX news now at Meyka AI. Stay informed with the latest Vanguard Equity Income Fund Admiral Shares stocks updates, including price news, market analysis, and expert insights.
M&M Ltd Share Price Rises 2.56% as Mahindra & Mahindra Sales Jump 37% in June to 1.06 Lakh Units
Mahindra & Mahindra reported total sales of 1,06,207 vehicles in June 2026. This marks a strong 37% jump from the same month last year. The impressive numbers lifted M&M Ltd shares by 2.56% in early trading as investors cheered the company’s growth momentum. Strong demand for SUVs and commercial vehicles is helping the automaker outperform…
Zee Media Share Price Rises 1% After ₹19.12 Crore Fundraise; FII Upps Stake to 3.33% via Warrant Conversion
Zee Media’s shares rose nearly 1% after the company announced a fresh capital infusion of ₹19.12 crore through warrant conversion. The move also pushed Foreign Institutional Investor (FII) ownership to 3.33%, highlighting growing institutional interest in the media company. The development comes as investors look for signs of recovery and stronger financial positioning in India’s…
IN Market Today: Sensex Gains 173 Points (+0.23%), Nifty 50 Rises 0.27%; GIFT Nifty Trades Lower
India’s benchmark indices closed the June quarter on a subdued note. The BSE Sensex fell 249.70 points, or 0.33%, to close at 76,478.67, while the Nifty 50 declined 80.50 points, or 0.34%, to settle at 23,865.75, slipping below the 23,900 mark. IT stocks led the selloff. GIFT Nifty futures declined 71 points, or 0.3%, to…
Dow Jones Crosses 52,000 for the First Time as Alphabet’s Strong Debut Fuels Tech, Led Rally
The Dow Jones reached a historic milestone after closing above 52,000 for the first time, reflecting renewed confidence in the US stock market. A strong earnings-driven rally in major technology stocks, especially Alphabet, lifted investor sentiment and pushed Wall Street to fresh record highs. Strong corporate earnings, continued optimism around artificial intelligence, and expectations of…
Alphabet Enters the Dow as Digital Economy Shift Accelerates, Sending GOOGL Shares Up 4.82% to $353.65
Alphabet Inc. (NASDAQ: GOOGL) shares surged 4.82% to $353.65 as the Google parent officially joined the Dow Jones Industrial Average on June 29, 2026. Alphabet replaced Verizon Communications Inc. (NYSE: VZ) effective before the opening of trading that day. S&P Dow Jones Indices first announced the swap on June 23, 2026. The change marks the…
Tech Stocks Recover Across Asia After Nasdaq’s 2% Surge, but Regional Markets Remain Cautious
The Nasdaq Composite surged more than 2% on June 29, 2026, giving global tech stocks a much-needed boost after weeks of market volatility. The rally quickly spread to Asia, where chipmakers and AI-related companies led early gains in Japan, South Korea, and Taiwan. Yet investors are still moving carefully. Concerns about high valuations, geopolitical tensions,…
Crypto Prices Today: Bitcoin Holds Near $59,357 While Solana Jumps 3.92% as Easing Iran Tensions Lift Q3 Sentiment
On June 30, 2026, Bitcoin traded near $59,357, holding steady after days of market volatility. At the same time, Solana jumped 3.92%, becoming one of the best-performing major cryptocurrencies of the day. The gains came as concerns over Iran-related tensions eased, improving investor confidence across global markets. The positive shift has sparked fresh optimism for…
Yen Hits 40-Year Low as USD/JPY Climbs to 162.41 Amid Intervention Fears
The yen slumped to levels unseen in four decades on June 30, 2026. The yen weakened to 162.41 per dollar for the first time in 40 years on Tuesday, while Japanese Finance Minister Satsuki Katayama reiterated that authorities stood ready to respond appropriately at any time. The yen fell to 162.19 per dollar as of…
Abivax Shares Soar 27% After Ulcerative Colitis Drug Shows Strong Results in Hard-to-Treat Patients
Abivax shares surged sharply after new clinical trial results for its ulcerative colitis treatment, obefazimod, showed strong performance in patients who previously failed standard therapies. The stock reaction reflects renewed investor confidence in the biotech pipeline and growing hopes for a breakthrough therapy in a difficult disease area. The move also comes at a time…